Blood Plasma Product Market Collection, Fractionation and Product Formation

Blood plasma product is the extracted portion from the blood using fractionation process to deliver products rich in plasma proteins. These products are used as body fluids, antibodies and clotting factors in medical industries that aid in treatment of chronic ailments like auto-immune disorders and haemophilia. The global blood plasma product market is expected to witness a significant growth during the forecast period due to the high demand by a large pool of patients with no alternative therapeutic approach. Blood plasma product have a wide range of components that have clinical use such as, Albumin, Factor VIII, Factor IX, immunoglobulin, fibrinogen with their major applications in bleeding disorders (haemophilia, immunological disorders), massive hemorrhage and in traumatic injuries. Moreover, the presence of biomarkers in plasma adds to their application in clinical diagnosis of diseases. These factors will drive the growth of global blood plasma product market in future.

Make enquiry before buying the report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=blood-plasma-product-market

Segmentation on the basis of application includes neurology, immunology, hematology, pulmonology, hemato-oncology, rheumatology, critical care and others. Globally, the demand for plasma product was largest in hospitals and clinics due to the large patient population. Other key end users in the global blood plasma product market are clinical research laboratories, and academic institutes.

Stringent regulatory standards on the import and export of plasma product hinder the growth of the global blood plasma product market. Other restraining factors includes the high complexity and cost associated with the collection of blood plasma, and dearth of trained and skilled professionals for fractionation process.

Access Report Overview: https://www.psmarketresearch.com/market-analysis/blood-plasma-product-market

Geographically, North America held the largest share in the global blood plasma product market in 2016, followed by Europe. North America was the prominent market for the blood plasma collection, fractionation and product formation. Asia Pacific global blood plasma product market is expected to witness the fastest growth during the forecast period (2017-2023). The growing geriatric population and the increase in prevalence of blood disorder diseases are the factors responsible for the growth.

The key players across the globe, are acquiring companies and units to enhance their portfolio and spreading geographically to gain large shares in the global blood plasma product market.

In June 2017, CSL Ltd., announced its first acquisition in Chinese market by acquiring Wuhan Zhong Yuan Rui De Biological Products Co. Ltd., a subsidiary of Humanwell Healthcare Co. Ltd. This will expand CSL Ltd. plasma collection and product portfolio in Asia Pacific’s blood plasma product market.

In August 2016, Creat Group Corporation acquired Bio Products Laboratory Ltd., a plasma biotherapeutics company, to expand in the global blood plasma product market.

In December 2016, Grifols S.A. acquired Hologic Inc., that will strengthen its global position by incorporating Nucleic acid testing (NAT) technology to enable transfusion safety in blood and plasma donations.

The other key players in the global market are Shire Pls., Octapharma AG, Kedrion S.p.A, Biotest AG, China Biologic Products, Inc., Sanquin and LFB S.A.

Contact:

P&S Market Research

Manager -Client Partner

Mr. Kundan Kumar

Manager – Client Partner

347, 5th Ave. #1402

New York City, NY – 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

 

Designed by CyFocus.com
Powered by CyFocus.net
%d bloggers like this: